ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980